Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere ... I would rather take an injectable weight-loss drug, rather than make a diet change.” More than half (62%) disagreed, with ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

For years, drug developers working to treat an advanced form of fatty liver disease known as MASH were chasing wide-open terrain. There were no products on the market, millions of ...

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Smoothie King says it is the first quick service restaurant brand with a GLP-1 focused menu.

These two drugs contributed to Novo's sales, but as can be seen in the above chart they ... dosing and presents another risk to the long-term sustainability of Novo's GLP-1 sales.

Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

"At the same time, expanded coverage could also increase Medicaid drug spending and put pressure on overall state budgets." Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone ...